引用本文：袁佳莹, 范小彧, 费博, 喻春钊. 结直肠癌肝转移研究模型的现状及展望[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(01): 40-46.Yuan JY, Fan XY, Fei B, Yu CZ. Current ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of patients diagnosed at ...

Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and genome duplication collide.

Colorectal cancer is the fourth-most-common cancer in the U.S. and the second deadliest. One in 5 patients is diagnosed with ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.